Neoplastic

NEC’s Artificial Intelligence (AI) Supports Doctors to Determine If Colorectal Lesions Are Potentially Neoplastic

– CE marking-compliant software; soon available in Europe – TOKYO–(BUSINESS WIRE)–NEC Corporation (NEC; TOKYO: 6701) announced today the development of…

Read More »